NuScale Power Reports Substantial Q1 Revenue Miss and Widening Net Loss Amidst Operational Progress

summarizeSummary

NuScale Power announced a significant first-quarter revenue miss and a wider net loss, primarily due to the completion of major projects in the prior year, though the company maintains a strong $1 billion liquidity position.

check_boxKey Events

• Substantial Revenue Decline

  First-quarter revenue decreased significantly to $565,000 in 2026 from $13.375 million in 2025, primarily due to the completion of major projects in the prior year with no comparable activity in the current quarter.

• Widening Net Loss

  The net loss attributable to Class A common stockholders widened to $44.015 million, or $(0.14) per share, in Q1 2026, compared to a net loss of $14.005 million, or $(0.11) per share, in Q1 2025.

• Strong Liquidity Position

  The company ended the first quarter with a robust $1.0 billion in cash, cash equivalents, and short- and long-term investments, providing significant capital resources.

• Operational Progress Noted

  NuScale highlighted continued progress on the Tennessee Valley Authority (TVA) program, shareholder approval for the next phase of the RoPower project in Romania, and an expanded supply chain partnership with Framatome.

auto_awesomeAnalysis

NuScale Power reported significantly weaker financial results for the first quarter of 2026, with revenue plummeting to $565,000 from $13.375 million in the prior year, and net loss widening to $44.015 million. This substantial decline in revenue is attributed to the completion of key projects in 2025, such as the RoPower technology license agreement and Fluor's FEED Phase 2 engineering services, with no comparable revenue-generating activities in the current quarter. Despite the poor financial performance, the company maintains a strong liquidity position of $1.0 billion, bolstered by previous capital raises, which provides a crucial financial runway. Operational updates, including progress on the TVA program, RoPower project approval, and an expanded partnership with Framatome, indicate continued long-term strategic development, but these do not offset the immediate negative financial impact.